Big4Bio News

life science

Big4Bio aggregates and presents the ongoing life science news, which is growing at an accelerated rate.

Life sciences research and discoveries are rapidly evolving through biomedical engineering, the interdisciplinary field where biology, chemistry, medicine, engineering, nanotechnology and computer science come together. The growing biomedical engineering news within our regions show that many startups with high potential are emerging constantly.

Big4Bio is constantly expanding and improving to deliver significant and newsworthy life science news to its readers. Keep up with the new Big4Bio announcements, updates and changes on this page.

Spotlight: Silicon Valley Bank Failure Rocks the Life Sciences

What it means to Big4Bio companies as well as ongoing media coverage On Wednesday, March 8, SVB Financial announced plans to raise $1.75 billion through the sale of shares to cover $1.8 billion in losses from securities sold by Silicon Valley Bank (SVB), located in Santa Clara, CA. Shares plummeted 60 percent the next day, […]

Read More

BigBio Communications Presents the 2022 Big4Bio Year-in-Reviews

SAN FRANCISCO – BigBio Communications proudly announces the publishing of the Big4Bio 2022 Year-in-Review (YIR) reports for each of the “Big 4” life science regions: Greater Boston, the San Francisco Bay Area, San Diego, and Philadelphia. Co-developed with KMA & Company, the YIR reports recap the most-clicked stories of each regions, industry market totals, statistics […]

Read More

Big4Bio Publishes 7th Edition of On Your Mark for the 2023 BioWeekSF/JPM Week

SAN FRANCISCO, CA–(December 2, 2022)–Big4Bio, the leading news aggregator service for the top biotech hubs in the United States, proudly announces the publishing of the 7th edition of On Your Mark, a compendium of virtual investor and partnering events revolving around the 41st Annual J.P. Morgan Healthcare Conference (#JPM23). As JPM Week/BioWeekSF returns to in-person […]

Read More

Big4Bio Announces Partnership With The Bullpen on Preparing for JPM Week 2023

Along with Big4Bio’s On Your Mark guide, this weekly series will help attendees plan for the week of the J.P. Morgan Healthcare Conference in San Francisco SAN FRANCISCO — (BUSINESS WIRE) — Big4Bio, the leading aggregator of life science news and developments in the top biohubs in the country, announces it is partnering with Christiaan […]

Read More

BigBio Communications Announces Upcoming Launch of BioStartup News

– Weekly Newsletter to Recap Developments of Life Science Startups Across the Country   SAN FRANCISCO–(BUSINESS WIRE)–BigBio Communications, publisher of Big4Bio, the premier aggregator of financial, clinical, and business news from the top life sciences regions, is proud to announce the upcoming launch of “BioStartup News” (biostartup.news), a weekly newsletter recapping the latest developments of […]

Read More

Big4Bio Announces the Publishing of the 2021 Big4Bio Year-in-Review Reports

SAN FRANCISCO – Big4Bio proudly announces the publishing of 2021 Year-in-Review (YIR) reports for each Big4Bio life science region, which not only recap the top industry news and developments that occurred within these areas in 2021, but also provides outlooks for 2022. Co-developed with KMA & Company, the 2021 YIRs also include content from local […]

Read More

Big4Bio Publishes Annual On Your Mark Guide for 2022 BioWeekSF/JPM Week

SAN FRANCISCO, CA–(December 16, 2021)–Big4Bio, the leading news aggregator service for the top biotech hubs in the United States, proudly announces the publishing of the 6th edition of On Your Mark, a compendium of virtual investor and partnering events revolving around the 40th Annual J.P. Morgan Healthcare Conference (#JPM2022). As J.P. Morgan has recently decided […]

Read More

Big4Bio and KMA & Co. Announce the Publishing of DEI 2021 Pivot Report

SAN FRANCISCO – Big4Bio and KMA & Company proudly announces the publishing of the organizations’ first pivot report, “DEI 2021,” which shares information about the Diversity, Equity, and Inclusion (DEI) activities, events, and strategies that have occurred within the Big4Bio life science regions in 2021. These “pivot reports” will be periodic reports from Big4Bio and […]

Read More

Big4Bio Announces Title Sponsorship of RESI Partnering Week

Big4Bio is joining forces with Life Science Nation (LSN) to bring insight and education to the community of investors, service providers, and early-stage companies as a Title Sponsor of LSN’s Redefining Early-Stage Investments (RESI) Partnering Week (RPW), taking place September 13-17, 2021. The week consists of: RESI, September 13-15, 2021 RESI AI, September 16-17, 2021 […]

Read More

The Big4Bio Company to Watch Program

The Big4Bio Company to Watch program is a month-long sponsored showcase that enables life science companies to give a unique and special perspective about their therapies, leaders, missions and more presented over multiple media platforms and partners, enabling an unrivaled outreach opportunity. This is an opportunity exclusively for life science organizations based, or with locations […]

Read More

BigBio Communications Launches The BioCalendar, The Premier Industry Calendar for Life Science Conferences and Events

SAN FRANCISCO–(BUSINESS WIRE)–BigBio Communications, developer of the life science industry news aggregator Big4Bio, proudly announces the launch of The BioCalendar (TheBioCalendar.com), an exclusive event listing platform for the global healthcare and biopharmaceutical industry. The BioCalendar was created to be the comprehensive calendar and guide for healthcare and life science industry event attendees worldwide, and also […]

Read More

Big4Bio-Area Companies Awarded NIH COVID-19 Test Contracts

From the NIH: “The National Institutes of Health is investing $248.7 million in new technologies to address challenges associated with COVID-19 testing (which detects SARS-CoV-2 coronavirus). NIH’s Rapid Acceleration of Diagnostics (RADx) initiative has awarded contracts to seven biomedical diagnostic companies to support a range of new lab-based and point-of-care tests that could significantly increase […]

Read More